Skip to main content

Want a detailed portfolio tracker?

CDT Equity (CDT) P/E (2023 - 2026)

CDT Equity (CDT) P/E from Sep 25, 2023 to Jul 21, 2026. The TTM CDT Equity (CDT) P/E is -0.09. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of CDT Equity (CDT)

YearP/EChange
2026-0.09-98.80%
2025-7.17-100.00%
2024264.02K-98.49%
202317.51MN/A

Comparison CDT Equity (CDT) P/E with competitors

CDT Equity (CDT) P/E is -0.09.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-101.98%
NBYStablecoin Development Corp0.00-105.01%
ENLVEnlivex Ltd0.07-187.14%
FGENFibroGen Inc0.24-379.64%
CHRSCoherus Biosciences Inc0.85-1088.50%
FBIOFortress Biotech Inc0.95-1205.58%
ORMPOramed Pharmaceuticals Inc1.50-1850.99%
AGENAgenus Inc3.01-3606.06%
INVAInnoviva Inc3.15-3774.29%
VXRTVaxart Inc3.55-4235.28%
CRMDCorMedix Inc3.63-4326.96%
CVACCureVac N.V.4.45-5279.00%
GLPGGalapagos NV4.86-5760.38%
SRPTSarepta Therapeutics Inc4.88-5787.40%
ABEOAbeona Therapeutics Inc5.39-6376.19%
ABUSArbutus Biopharma Corp5.60-6618.63%
ZVRAZevra Therapeutics Inc5.89-6958.34%
SPROSpero Therapeutics Inc6.23-7355.84%
CGENCompugen Ltd6.31-7455.45%
RIGLRigel Pharmaceuticals6.87-8105.63%
SLXNSilexion Therapeutics Corp7.30-8599.59%
OMEROmeros Corporation9.26-10886.02%
AUPHAurinia Pharmaceuticals Inc9.58-11266.04%
PLXProtalix BioTherapeutics Inc10.89-12787.53%
ACADAcadia Pharmaceuticals Inc11.73-13763.21%
TBPHTheravance Biopharma Inc12.26-14384.86%
ADMAAdma Biologics Inc12.42-14566.60%
HRMYHarmony Biosciences Holdings Inc13.82-16199.92%
SABSSAB Biotherapeutics Inc14.14-16568.06%
NAGENiagen Bioscience Inc14.82-17362.48%
INCYIncyte Corp15.82-18532.60%
REGNRegeneron Pharmaceuticals Inc15.86-18572.33%
PBYIPuma Biotechnology Inc17.32-20272.06%
CPRXCatalyst Pharmaceuticals Inc17.44-20416.05%
EXELExelixis Inc17.54-20531.04%
TGTXTG Therapeutics Inc18.97-22194.65%
MDXGMimedx Group Inc20.55-24042.81%
XOMAXOMA Royalty Corp22.87-26748.75%
ARGXArgen X SE24.30-28406.89%
CTMXCytomX Therapeutics Inc24.82-29016.30%
XOMAOXOMA Royalty Corp25.34-29626.41%
HALOHalozyme Therapeutics Inc25.62-29951.33%
XOMAPXOMA Royalty Corp25.67-30005.38%
VRTXVertex Pharmaceuticals Inc27.99-32713.54%
RPRXRoyalty Pharma plc - Class A28.69-33520.65%
SLNOSoleno Therapeutics Inc29.02-33902.54%
ASNDAscendis Pharma A/S30.09-35149.32%
LGNDLigand Pharmaceuticals Inc - Class B37.91-44267.06%
APLSApellis Pharmaceuticals Inc39.02-45559.27%
BMRNBiomarin Pharmaceutical Inc42.21-49276.32%
KRYSKrystal Biotech Inc45.34-52924.62%
ONCBeiGene Ltd69.54-81113.85%
PHARPharming Group N.V.75.03-87503.98%
TECHBio-Techne Corp101.96-118880.41%
VCELVericel Corp109.92-128157.17%
ALNYAlnylam Pharmaceuticals Inc117.96-137528.07%
GMABGenmab140.29-163537.23%
TLXTelix Pharmaceuticals Ltd162.15-189006.30%
CORTCorcept Therapeutics Inc212.86-248076.72%